The Economic Times

Eyestem presents interim Phase 2 data for Eyecyte-RPE at EURetina 2026 Conference

Eyestem Research has presented interim results from its Phase 2 clinical trial of Eyecyte-RPE. The trial focuses on Geographic Atrophy secondary to dry age-related macular degeneration.